Search results
Results from the WOW.Com Content Network
JUBLIA ® (efinaconazole) topical solution, 10%, is a prescription medicine used to treat fungal infections of the toenails. To report SUSPECTED ADVERSE REACTIONS, contact Ortho Dermatologics at 1-800-321-4576 or the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch .
JUBLIA (efinaconazole) topical solution, 10%, is specifically formulated to reach the site of onychomycosis to treat toenail fungus. Follow the steps below to apply JUBLIA with its flow-through brush applicator.
JUBLIA ® (efinaconazole) topical solution, 10%, is a prescription medicine used to treat fungal infections of the toenails. To report SUSPECTED ADVERSE REACTIONS, contact Ortho Dermatologics at 1-800-321-4576 or the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch .
Read about the clinically proven results with JUBLIA® (efinaconazole) in treating toenail fungus and learn about side effects.
JUBLIA ® (efinaconazole) topical solution, 10%, is indicated for the topical treatment of onychomycosis (tinea unguium) of the toenail (s) due to Trichophyton rubrum and Trichophyton mentagrophytes.
JUBLIA ® (efinaconazole) topical solution, 10%, is a prescription medicine used to treat fungal infections of the toenails. To report SUSPECTED ADVERSE REACTIONS, contact Ortho Dermatologics at 1-800-321-4576 or the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch .
JUBLIA ® (efinaconazole) topical solution, 10%, is indicated for the topical treatment of onychomycosis (tinea unguium) of the toenail(s) due to Trichophyton rubrum and Trichophyton mentagrophytes. Important Safety Information. JUBLIA is for topical use only and is not for oral, ophthalmic, or intravaginal use.
Read frequently asked questions about JUBLIA® (efinaconazole), an FDA-approved prescription topical treatment for toenail fungus (onychomycosis).
JUBLIA is an azole antifungal dosed once daily for 48 weeks for the treatment of onychomycosis of the toenail (s). The formulation properties of JUBLIA, such as low surface tension, and the low keratin binding affinity of efinaconazole, may help JUBLIA reach the site of infection when applied as directed. 1-3.
Evaluate clinical results for JUBLIA® (efinaconazole) in achieving complete or almost complete cure for onychomycosis. See complete results here.